skip to Main Content
large burst
light ray
upper burst

Unlock the
power of proteins®

Apply our revolutionary CodeEvolver® platform technology to deliver high-performing enzymes and customized solutions in a wide array of applications.

Watch the video


Improve production processes with state-of-the-art enzymes.

Learn More



Create novel therapeutic proteins with highly optimized performance.

Learn More


Food & Beverage

Impact product quality and profitability with expert protein engineering.

Learn More


Life Sciences

Accelerate genomics research and development with powerful enzyme solutions.

Learn More


“We view Codexis as an extension of our internal research and development programs at Tate & Lyle and are excited about the opportunities which this partnership brings to deliver new and innovative food ingredients to the market.”

Michael Harrison, Senior Vice President of New Product Development
Tate & Lyle

“[Codexis’] process, which won a 2010 Presidential Green Chemistry Award, increased sitagliptin yield, cut back on production steps, and reduced water use and waste. The advance led to a threefold increase in productivity and helped us avoid the cost of building a second factory to meet rising demand for Januvia.”

R.P. "Skip" Volante, Vice President of R&D

“We chose the Codexis platform after a thorough evaluation of the enzyme evolution landscape. Codexis has a significant track record of delivering evolved biocatalysts for pharmaceutical and fine chemical applications over an extended period of time.”

Doug Fuerst, Technology Development Lead, Synthetic Biology

“The partnership with Codexis strengthens our footprint in the enzyme field, a fast-developing part of the nutritional therapy innovation frontier that is changing the way we manage our health.”

Greg Behar, CEO
Nestlé Health Science

Latest News

06Aug 20

Codexis Reports Second Quarter 2020 Financial Results

Revenues increased 21% to $15 million ; 72% rise in R&D revenue included a significant contribution from the Takeda biotherapeutics partnership Conference call with slides begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE…
read more
06Aug 20

Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker , Ph.D. to its board of directors, expanding membership…
read more
Back To Top
Close search